ReP USP - Resultado da busca

Artigo de periodico
Clinical and molecular determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria (2023)
Gurnari, Carmelo; Pagliuca, Simona; Prata, Pedro Henrique de Lima ; Galimard, Jacques-Emmanuel; Catto, Luiz Fernando Bazzo ; Larcher, Lise; Sebert, Marie; Allain, Vincent; Santos, André Luiz Pinto ; Inacio, Mariana Carolina Beraldo; Calado, Rodrigo Tocantins ; Socié, Gérard; Maciejewski, Jaroslaw P.
Source: Journal of Clinical Oncology. Unidade: FMRP
Subjects: ANEMIA, NEOPLASIAS, CÉLULAS MIELOIDES, ESTUDOS TRANSVERSAIS, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GURNARI, Carmelo et al. Clinical and molecular determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria. Journal of Clinical Oncology, v. 41, n. 1, p. 132-142, 2023Tradução . . Disponível em: https://doi.org/10.1200/JCO.22.00710. Acesso em: 06 jan. 2026.
APA
Gurnari, C., Pagliuca, S., Prata, P. H. de L., Galimard, J. -E., Catto, L. F. B., Larcher, L., et al. (2023). Clinical and molecular determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria. Journal of Clinical Oncology, 41( 1), 132-142. doi:10.1200/JCO.22.00710
NLM
Gurnari C, Pagliuca S, Prata PH de L, Galimard J-E, Catto LFB, Larcher L, Sebert M, Allain V, Santos ALP, Inacio MCB, Calado RT, Socié G, Maciejewski JP. Clinical and molecular determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria [Internet]. Journal of Clinical Oncology. 2023 ; 41( 1): 132-142.[citado 2026 jan. 06 ] Available from: https://doi.org/10.1200/JCO.22.00710
Vancouver
Gurnari C, Pagliuca S, Prata PH de L, Galimard J-E, Catto LFB, Larcher L, Sebert M, Allain V, Santos ALP, Inacio MCB, Calado RT, Socié G, Maciejewski JP. Clinical and molecular determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria [Internet]. Journal of Clinical Oncology. 2023 ; 41( 1): 132-142.[citado 2026 jan. 06 ] Available from: https://doi.org/10.1200/JCO.22.00710
Artigo de periodico-carta/editorial
IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria [Carta] (2023)
Gurnari, Carmelo; Prata, Pedro Henrique de Lima; Catto, Luiz Fernando Bazzo ; Durmaz, Arda; Pinto, André Luiz; Inacio, Mariana Carolina Beraldo; Hernandez, Lucie; Dhedin, Nathalie; Visconte, Valeria; Soulier, Jean; Calado, Rodrigo Tocantins
Source: Blood. Unidade: FMRP
Subjects: ANEMIA, NEOPLASIAS, DOENÇAS RARAS, LEUCEMIA MIELOIDE AGUDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GURNARI, Carmelo et al. IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria [Carta]. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood.2023020108. Acesso em: 06 jan. 2026. , 2023
APA
Gurnari, C., Prata, P. H. de L., Catto, L. F. B., Durmaz, A., Pinto, A. L., Inacio, M. C. B., et al. (2023). IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria [Carta]. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood.2023020108
NLM
Gurnari C, Prata PH de L, Catto LFB, Durmaz A, Pinto AL, Inacio MCB, Hernandez L, Dhedin N, Visconte V, Soulier J, Calado RT. IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria [Carta] [Internet]. Blood. 2023 ; 141( 25): 3122-3125.[citado 2026 jan. 06 ] Available from: https://doi.org/10.1182/blood.2023020108
Vancouver
Gurnari C, Prata PH de L, Catto LFB, Durmaz A, Pinto AL, Inacio MCB, Hernandez L, Dhedin N, Visconte V, Soulier J, Calado RT. IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria [Carta] [Internet]. Blood. 2023 ; 141( 25): 3122-3125.[citado 2026 jan. 06 ] Available from: https://doi.org/10.1182/blood.2023020108
Artigo de periodico-carta/editorial
Direct oral anticoagulant versus low molecular weight heparin for the treatment of cancer-associated venous thromboembolism. [Carta]: 2022 updated systematic review and meta-analysis of randomized controlled trials (2022)
Frere, Corinne; Farge, Dominique; Schrag, Deborah; Prata, Pedro Henrique de Lima ; Connors, Jean M.
Source: Journal of Hematology & Oncology. Unidade: FMRP
Subjects: ANTICOAGULANTES, TROMBOEMBOLISMO, NEOPLASIAS, ENSAIO CLÍNICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRERE, Corinne et al. Direct oral anticoagulant versus low molecular weight heparin for the treatment of cancer-associated venous thromboembolism. [Carta]: 2022 updated systematic review and meta-analysis of randomized controlled trials. Journal of Hematology & Oncology. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1186/s13045-022-01289-1. Acesso em: 06 jan. 2026. , 2022
APA
Frere, C., Farge, D., Schrag, D., Prata, P. H. de L., & Connors, J. M. (2022). Direct oral anticoagulant versus low molecular weight heparin for the treatment of cancer-associated venous thromboembolism. [Carta]: 2022 updated systematic review and meta-analysis of randomized controlled trials. Journal of Hematology & Oncology. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1186/s13045-022-01289-1
NLM
Frere C, Farge D, Schrag D, Prata PH de L, Connors JM. Direct oral anticoagulant versus low molecular weight heparin for the treatment of cancer-associated venous thromboembolism. [Carta]: 2022 updated systematic review and meta-analysis of randomized controlled trials [Internet]. Journal of Hematology & Oncology. 2022 ; 15( 1):[citado 2026 jan. 06 ] Available from: https://doi.org/10.1186/s13045-022-01289-1
Vancouver
Frere C, Farge D, Schrag D, Prata PH de L, Connors JM. Direct oral anticoagulant versus low molecular weight heparin for the treatment of cancer-associated venous thromboembolism. [Carta]: 2022 updated systematic review and meta-analysis of randomized controlled trials [Internet]. Journal of Hematology & Oncology. 2022 ; 15( 1):[citado 2026 jan. 06 ] Available from: https://doi.org/10.1186/s13045-022-01289-1
Artigo de periodico
A review of latest clinical practice guidelines for the management of cancer-associated thrombosis (2022)
Frere, Corinne; Wahl, Clementine; Rueda-Camino, Jose A.; Crichi, Benjamin; Prata, Pedro Henrique de Lima ; Marjanovic, Zora; Farge, Dominique
Source: Best Practice & Research: Clinical Haematology. Unidade: FMRP
Subjects: TROMBOSE, NEOPLASIAS, PRÁTICA CLÍNICA, REVISÃO SISTEMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRERE, Corinne et al. A review of latest clinical practice guidelines for the management of cancer-associated thrombosis. Best Practice & Research: Clinical Haematology, v. 35, p. 1-20, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.beha.2022.101348. Acesso em: 06 jan. 2026.
APA
Frere, C., Wahl, C., Rueda-Camino, J. A., Crichi, B., Prata, P. H. de L., Marjanovic, Z., & Farge, D. (2022). A review of latest clinical practice guidelines for the management of cancer-associated thrombosis. Best Practice & Research: Clinical Haematology, 35, 1-20. doi:10.1016/j.beha.2022.101348
NLM
Frere C, Wahl C, Rueda-Camino JA, Crichi B, Prata PH de L, Marjanovic Z, Farge D. A review of latest clinical practice guidelines for the management of cancer-associated thrombosis [Internet]. Best Practice & Research: Clinical Haematology. 2022 ; 35 1-20.[citado 2026 jan. 06 ] Available from: https://doi.org/10.1016/j.beha.2022.101348
Vancouver
Frere C, Wahl C, Rueda-Camino JA, Crichi B, Prata PH de L, Marjanovic Z, Farge D. A review of latest clinical practice guidelines for the management of cancer-associated thrombosis [Internet]. Best Practice & Research: Clinical Haematology. 2022 ; 35 1-20.[citado 2026 jan. 06 ] Available from: https://doi.org/10.1016/j.beha.2022.101348
Trabalho de evento-resumo periodico
Immunogenetic, molecular and clinical determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria (2021)
Gurnari, Carmelo; Pagliuca, Simona; Prata, Pedro Henrique de Lima; Catto, Luiz Fernando Bazzo ; Larcher, Lise; Sebert, Marie; Allain, Vincent; Patel, Bhumika J.; Terkawi, Laila; Santos, André Luiz Pinto ; Inacio, Mariana Carolina Beraldo; Hernandez, Lucie; Dhedin, Nathalie; Caillat-Zucman, Sophie; Clappier, Emmanuelle; Fontbrune, Flore Sicre de; Voso, Maria Teresa; Visconte, Valeria; Socie, Gerard; Calado, Rodrigo Tocantins ; Peffault de Latour, Regis; Soulier, Jean; Maciejewski, Jaroslaw P.
Source: Blood. Conference titles: ASH Annual Meeting Abstracts. Unidade: FMRP
Subjects: ANEMIA, CONTAGEM DE CÉLULAS SANGUÍNEAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GURNARI, Carmelo et al. Immunogenetic, molecular and clinical determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2021-147556. Acesso em: 06 jan. 2026. , 2021
APA
Gurnari, C., Pagliuca, S., Prata, P. H. de L., Catto, L. F. B., Larcher, L., Sebert, M., et al. (2021). Immunogenetic, molecular and clinical determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2021-147556
NLM
Gurnari C, Pagliuca S, Prata PH de L, Catto LFB, Larcher L, Sebert M, Allain V, Patel BJ, Terkawi L, Santos ALP, Inacio MCB, Hernandez L, Dhedin N, Caillat-Zucman S, Clappier E, Fontbrune FS de, Voso MT, Visconte V, Socie G, Calado RT, Peffault de Latour R, Soulier J, Maciejewski JP. Immunogenetic, molecular and clinical determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria [Internet]. Blood. 2021 ; 138 602-602.[citado 2026 jan. 06 ] Available from: https://doi.org/10.1182/blood-2021-147556
Vancouver
Gurnari C, Pagliuca S, Prata PH de L, Catto LFB, Larcher L, Sebert M, Allain V, Patel BJ, Terkawi L, Santos ALP, Inacio MCB, Hernandez L, Dhedin N, Caillat-Zucman S, Clappier E, Fontbrune FS de, Voso MT, Visconte V, Socie G, Calado RT, Peffault de Latour R, Soulier J, Maciejewski JP. Immunogenetic, molecular and clinical determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria [Internet]. Blood. 2021 ; 138 602-602.[citado 2026 jan. 06 ] Available from: https://doi.org/10.1182/blood-2021-147556
Artigo de periodico-carta/editorial
Categorizing hematological response to eculizumab in paroxysmal nocturnal hemoglobinuria [Carta]: a multicenter real-life study (2021)
Debureaux, Pierre-Edouard; Kulasekararaj, Austin G.; Cacace, Fabiana; Silva, Bruno Garcia Peixoto Pires da; Calado, Rodrigo Tocantins ; Barone, Federica; Fontbrune, Flore Sicre de; Prata, Pedro Henrique de Lima ; Soret, Juliette; Sica, Michela; Notaro, Rosario; Scheinberg, Phillip ; Mallikarjuna, Vasundhara; Gandhi, Shreyans; Large, Joanna; Risitano, Antonio M.; Latour, Régis Peffault de; Frieri, Camilla
Source: Bone Marrow Transplantation. Unidade: FMRP
Subjects: ANTICORPOS MONOCLONAIS, HEMOGLOBINAS, ESTUDOS MULTICÊNTRICOS, TROMBOEMBOLISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DEBUREAUX, Pierre-Edouard et al. Categorizing hematological response to eculizumab in paroxysmal nocturnal hemoglobinuria [Carta]: a multicenter real-life study. Bone Marrow Transplantation. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1038/s41409-021-01372-0. Acesso em: 06 jan. 2026. , 2021
APA
Debureaux, P. -E., Kulasekararaj, A. G., Cacace, F., Silva, B. G. P. P. da, Calado, R. T., Barone, F., et al. (2021). Categorizing hematological response to eculizumab in paroxysmal nocturnal hemoglobinuria [Carta]: a multicenter real-life study. Bone Marrow Transplantation. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1038/s41409-021-01372-0
NLM
Debureaux P-E, Kulasekararaj AG, Cacace F, Silva BGPP da, Calado RT, Barone F, Fontbrune FS de, Prata PH de L, Soret J, Sica M, Notaro R, Scheinberg P, Mallikarjuna V, Gandhi S, Large J, Risitano AM, Latour RP de, Frieri C. Categorizing hematological response to eculizumab in paroxysmal nocturnal hemoglobinuria [Carta]: a multicenter real-life study [Internet]. Bone Marrow Transplantation. 2021 ; 56( 10): 2600-2602.[citado 2026 jan. 06 ] Available from: https://doi.org/10.1038/s41409-021-01372-0
Vancouver
Debureaux P-E, Kulasekararaj AG, Cacace F, Silva BGPP da, Calado RT, Barone F, Fontbrune FS de, Prata PH de L, Soret J, Sica M, Notaro R, Scheinberg P, Mallikarjuna V, Gandhi S, Large J, Risitano AM, Latour RP de, Frieri C. Categorizing hematological response to eculizumab in paroxysmal nocturnal hemoglobinuria [Carta]: a multicenter real-life study [Internet]. Bone Marrow Transplantation. 2021 ; 56( 10): 2600-2602.[citado 2026 jan. 06 ] Available from: https://doi.org/10.1038/s41409-021-01372-0

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Indexado em

Non normalized affiliation

Countries of institutions of collaboration